Mangoceuticals (MGRX) Cash from Investing Activities (2023)
Mangoceuticals' (MGRX) quarterly Cash from Investing Activities came in at -$3519.0 in Q1 2023.
Powered by 
Analysis
Mangoceuticals (MGRX) Cash from Investing Activities (2023) Analysis & Trends
Mangoceuticals has disclosed Cash from Investing Activities across 1 years of filings, most recently posting -$3519.0 for Q1 2023.
- In Q1 2023, Cash from Investing Activities changed N/A year-over-year to -$3519.0; the TTM figure through Dec 2023 stood at -$3519.0 (changed N/A YoY), while the FY2024 annual figure was $65000.0, up 1947.12% from the prior year.
- Cash from Investing Activities came in at -$3519.0 for Q1 2023 at Mangoceuticals.
- In the past five years, Cash from Investing Activities ranged from a high of -$3519.0 in Q1 2023 to a low of -$3519.0 in Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Hinge Health | 7.41 Bn | 7.03 Bn | 183.95 Mn | 28.62 Mn |
| 2 | Hims & Hers Health | 6.47 Bn | 5.63 Bn | 480.80 Mn | 84.54 Mn |
| 3 | Ethos Technologies | 2.54 Bn | 2.37 Bn | 185.54 Mn | -26.99 Mn |
| 4 | Omada Health | 1.38 Bn | 1.16 Bn | 63.79 Mn | -1.66 Mn |
| 5 | Teladoc Health | 1.14 Bn | 366.41 Mn | 416.09 Mn | -41.59 Mn |
| 6 | Talkspace | 870.58 Mn | 779.48 Mn | 24.80 Mn | -2.04 Mn |
| 7 | Akso Health | 259.44 Mn | 259.25 Mn | - | - |
| 8 | LifeMD | 147.29 Mn | 147.29 Mn | - | - |
| 9 | eHealth | 31.71 Mn | -69.34 Mn | - | 1.93 Mn |
| 10 | Mangoceuticals | 7.39 Mn | 7.14 Mn | 44,215.00 | - |